Conditions: Hypertension
Enrollment: 976
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to assess the efficacy and safety of the fixed dose combinations telmisartan 40 mg / amlodipine 5 mg (T40/A5) or telmisartan 80 mg / amlodipine 5 mg (T80/A5) during long-term open-label treatment.

Detailed description:

Arms:

Interventions: intervention 1: telmisartan/amlodipine 40/5 mg fixed combination intervention 2: telmisartan/amlodipine 80/5 mg fixed combination
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: